Yeh, Y.-S., Evans, T. D., Iwase, M., Jeong, S.-J., Zhang, X., Liu, Z., Park, A., Ghasemian, A., Dianati, B., Javaheri, A., Kratky, D., Kawarasaki, S., Goto, T., Zhang, H., Dutta, P., Schopfer, F. J., Straub, A. C., Cho, J., Lodhi, I. J., & Razani, B. (2025). Identification of lysosomal lipolysis as an essential noncanonical mediator of adipocyte fasting and cold-induced lipolysis. Journal of Clinical Investigation, 135(6). https://doi.org/10.1172/jci185340

Park, M., Nam, J. S., Kim, T., Yoon, G., Kim, S., Lee, C., Lee, C. G., Park, S., Bejoymohandas, K. S., Yang, J., Kwon, Y. H., Lee, Y. J., Seo, J. K., Min, D., Park, T., & Kwon, T. (2024). Rational Design of Biocompatible Ir(III) Photosensitizer to Overcome Drug‐Resistant Cancer via Oxidative Autophagy Inhibition. Advanced Science. Portico. https://doi.org/10.1002/advs.202407236

Barbuti, P. A. (2024). A-Syn(ful) MAM: A Fresh Perspective on a Converging Domain in Parkinson’s Disease. International Journal of Molecular Sciences, 25(12), 6525. https://doi.org/10.3390/ijms25126525

Herman, M., Randall, G. W., Spiegel, J. L., Maldonado, D. J., & Simoes, S. (2024). Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers. Philosophical Transactions of the Royal Society B: Biological Sciences, 379(1899). https://doi.org/10.1098/rstb.2022.0387

Manji, G. A., Labadie, B. W., Lee, S. M., Pellicciotta, I., Ge, L., Sta Ana, S., Sender, N., Ross, I., Wong, W., & Raufi, A. G. (2023). MEKiAUTO: A multicenter phase 1 study of combination therapy with the MEK inhibitor, cobimetinib, immune checkpoint blockade, atezolizumab, and the autophagy inhibitor hydroxychloroquine (HCQ) in KRAS-mutated advanced malignancies. JCO Global Oncology, 9(Supplement_1), 45–45. https://doi.org/10.1200/go.2023.9.supplement_1.45

Planas-Serra, L., Launay, N., Goicoechea, L., Heron, B., Jou, C., Juliá-Palacios, N., Ruiz, M., Fourcade, S., Casasnovas, C., De La Torre, C., Gelot, A., Marsal, M., Loza-Alvarez, P., García-Cazorla, À., Fatemi, A., Ferrer, I., Portero-Otin, M., Area-Gómez, E., & Pujol, A. (2023). Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity. Journal of Clinical Investigation, 133(10). https://doi.org/10.1172/jci162957

Hadisurya, M., Li, L., Kuwaranancharoen, K., Wu, X., Lee, Z.-C., Alcalay, R. N., Padmanabhan, S., Tao, W. A., & Iliuk, A. (2023). Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease. Communications Medicine, 3(1). https://doi.org/10.1038/s43856-023-00294-w

Shi, J., Wu, X., Wang, Z., Li, F., Meng, Y., Moore, R. M., Cui, J., Xue, C., Croce, K. R., Yurdagul, A., Doench, J. G., Li, W., Zarbalis, K. S., Tabas, I., Yamamoto, A., & Zhang, H. (2022). A genome-wide CRISPR screen identifies WDFY3 as a regulator of macrophage efferocytosis. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-35604-8

Birdsall, V., Kirwan, K., Zhu, M., Imoto, Y., Wilson, S. M., Watanabe, S., & Waites, C. L. (2022). Axonal transport of Hrs is activity dependent and facilitates synaptic vesicle protein degradation. Life Science Alliance, 5(10), e202000745. https://doi.org/10.26508/lsa.202000745

Chambers, J. E., Zubkov, N., Kubánková, M., Nixon-Abell, J., Mela, I., Abreu, S., Schwiening, M., Lavarda, G., López-Duarte, I., Dickens, J. A., Torres, T., Kaminski, C. F., Holt, L. J., Avezov, E., Huntington, J. A., George-Hyslop, P. S., Kuimova, M. K., & Marciniak, S. J. (2022). Z-α1-antitrypsin polymers impose molecular filtration in the endoplasmic reticulum after undergoing phase transition to a solid state. Science Advances, 8(14). https://doi.org/10.1126/sciadv.abm2094

Yao, M., Fei, Y., Zhang, S., Qiu, B., Zhu, L., Li, F., Berglund, B., Xiao, H., & Li, L. (2022). Gut Microbiota Composition in Relation to the Metabolism of Oral Administrated Resveratrol. Nutrients, 14(5), 1013. https://doi.org/10.3390/nu14051013

Dong, C., Honrao, C., Rodrigues, L. O., Wolf, J., Sheehan, K. B., Surface, M., Alcalay, R. N., & O’Day, E. M. (2022). Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients. Metabolites, 12(2), 149. https://doi.org/10.3390/metabo12020149